| Code | 7058D | ||||||||||
| MA number | 29/0086/21-S | ||||||||||
| Product Form: | tbl flm 100x400 mg (blis.PVC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Zentiva k.s., Czechia | ||||||||||
| Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 29.03.2021 |
| Validity: | 29.03.2026 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Ibuprofén Zentiva k.s. 400 mg_05.2023.pdf
|
| PIL: |
PIL_Ibuprofén Zentiva k.s. 400 mg_Rx_05.2023.pdf
|
| PIL: |
PIL_Ibuprofén Zentiva k.s. 400 mg_OTC_05.2023.pdf
|
| Safety feature | Yes |
| Data update: | 07.07.2021 |
